Clinical Trial Update: CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial update on chemo-immunotherapy with early CNS prophylaxis in primary disease; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease

Snippet

Sponsor: Nordic Lymphoma Group | Conditions: Primary Disease | Phase 2 | Status: COMPLETED